Delivery Order SPE2DB20D1004-SPE2DB24FG6V0
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,556 units of Lisinopril-HCTZ 20-12.5 mg tablets in 1,000 count bottles. The $1,418.22 firm-fixed price delivery order has an ultimate completion date of August 26, 2024. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for supplying a...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB24FN1M5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,156.33 firm fixed-price delivery order is for the supply of 4,564,043,828 units of the drug Lisinopril-HCTZ 10-12.5 mg tablets. The contract has a completion date of March 22, 2024 and was awarded on March 21, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award, valued at $1,266.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB22D1041|SPE2DB25FUAP8) for the supply of 4,568,175,234 tablets of the drug Lisinopril 10 mg. The contract has an ultimate completion date of May 8, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Lisinopril-HCTZ 20-25 mg. The single-award, firm-fixed price delivery order, valued at $2,066.47, has a completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,048.21, is for the supply of Lisinopril-HCTZ 10-12.5 mg tablets in 1,000 tablet quantities. The contract has an ultimate completion date of August 13, 2024 and is a Firm Fixed Price contract. This order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,157.75 firm fixed-price delivery order is for 4,564,886,290 tablets of the drug Lisinopril 10 mg. The contract has a completion date of June 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB23FL4G6, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,152.94 firm fixed-price delivery order is for 1,000 units of the medication Lisinopril-HCTZ 10-12.5 mg tablets. This contract has an ultimate completion date of October 25, 2022 and was awarded on October 24, 2022. It is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award SPE2DB22D1017|SPE2DB24FF9SQ was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,228.57 firm fixed-price delivery order is for the supply of 1,000 Lisinopril-HCTZ 20-12.5 mg tablets, with a completion date of June 18, 2024. This award is not part of a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $1,243.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,701,371 units of Lisinopril 20 mg tablets, a cardiovascular medication, with an ultimate completion date of April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is for the delivery of Lisinopril-HCTZ 20-12.5 mg tablets in 1,000 count sizes. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment...